You just read:

Veloxis' Phase 3 Trial of LCP-Tacro™ in Stable Kidney Transplant Patients, the 3001 Study, Published Online in the American Journal of Transplantation

News provided by

Veloxis Pharmaceuticals A/S

Jan 03, 2013, 08:00 EST